112 related articles for article (PubMed ID: 25845720)
21. Anti-Candida activity and in vitro toxicity screening of antifungals complexed with β-cyclodextrin.
Moraes GS; Tozetto NM; Pedroso TAA; de Mattos MA; Urban AM; Paludo KS; Dos Santos FA; Neppelenbroek KH; Urban VM
J Appl Toxicol; 2024 May; 44(5):747-755. PubMed ID: 38198744
[TBL] [Abstract][Full Text] [Related]
22. An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents.
Ohnemus U; Willers C; Bubenheim M; Horstkotte MA; Houdek P; Fischer F; Schmage P; Moll I; Brandner JM
Mycoses; 2008 Jan; 51(1):21-9. PubMed ID: 18076591
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic effects of three trichothecenes in the silkworm infection assay with Candida albicans.
Uchida R; Namiguchi S; Ishijima H; Tomoda H
Drug Discov Ther; 2016 Feb; 10(1):44-8. PubMed ID: 26971555
[TBL] [Abstract][Full Text] [Related]
24. Antifungal activity against planktonic and biofilm Candida albicans in an experimental model of foreign-body infection.
Maiolo EM; Oliva A; Furustrand Tafin U; Perrotet N; Borens O; Trampuz A
J Infect; 2016 Mar; 72(3):386-92. PubMed ID: 26723911
[TBL] [Abstract][Full Text] [Related]
25. Interactions between Terpinen-4-ol and Nystatin on biofilm of Candida albicans and Candida tropicalis.
Tonon CC; Francisconi RS; Bordini EAF; Huacho PMM; Sardi JCO; Spolidorio DMP
Braz Dent J; 2018; 29(4):359-367. PubMed ID: 30462762
[TBL] [Abstract][Full Text] [Related]
26. Antifungal activity of coronarin D against Candida albicans.
Kaomongkolgit R; Jamdee K; Wongnoi S; Chimnoi N; Techasakul S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):61-6. PubMed ID: 22727093
[TBL] [Abstract][Full Text] [Related]
27. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic.
Silva S; Pires P; Monteiro DR; Negri M; Gorup LF; Camargo ER; Barbosa DB; Oliveira R; Williams DW; Henriques M; Azeredo J
Med Mycol; 2013 Feb; 51(2):178-84. PubMed ID: 22803822
[TBL] [Abstract][Full Text] [Related]
28. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
[TBL] [Abstract][Full Text] [Related]
29. Experimental evidences for a role of subinhibitory concentrations of rilopirox, nystatin and fluconazole on adherence of Candida spp. to vaginal epithelial cells.
Braga PC; Maci S; Dal Sasso M; Bohn M
Chemotherapy; 1996; 42(4):259-65. PubMed ID: 8804793
[TBL] [Abstract][Full Text] [Related]
30. Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity.
Alves TP; Simões AC; Soares RM; Moreno DS; Portela MB; Castro GF
Arch Oral Biol; 2014 Aug; 59(8):775-82. PubMed ID: 24837476
[TBL] [Abstract][Full Text] [Related]
31. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
[TBL] [Abstract][Full Text] [Related]
32. Silver(I) complexes with 4,7-phenanthroline efficient in rescuing the zebrafish embryos of lethal Candida albicans infection.
Pavic A; Savić ND; Glišić BĐ; Crochet A; Vojnovic S; Kurutos A; Stanković DM; Fromm KM; Nikodinovic-Runic J; Djuran MI
J Inorg Biochem; 2019 Jun; 195():149-163. PubMed ID: 30952084
[TBL] [Abstract][Full Text] [Related]
33. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
El-Azizi M; Farag N; Khardori N
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.
Prażyńska M; Bogiel T; Gospodarek-Komkowska E
Folia Microbiol (Praha); 2018 Mar; 63(2):209-216. PubMed ID: 28983822
[TBL] [Abstract][Full Text] [Related]
35. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
[TBL] [Abstract][Full Text] [Related]
36. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
Khan F; Baqai R
J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
[TBL] [Abstract][Full Text] [Related]
37. Antifungal susceptibility of Candida albicans in biofilms.
Tobudic S; Kratzer C; Lassnigg A; Presterl E
Mycoses; 2012 May; 55(3):199-204. PubMed ID: 21793943
[TBL] [Abstract][Full Text] [Related]
38. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of activity and toxicity of Nystatin-Intralipid.
Semis R; Kagan S; Berdicevsky I; Polacheck I; Segal E
Med Mycol; 2013 May; 51(4):422-31. PubMed ID: 23088298
[TBL] [Abstract][Full Text] [Related]
40. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds.
Acar A; Uygur F; Diktaş H; Evinç R; Ulkür E; Oncül O; Görenek L
Burns; 2011 Aug; 37(5):882-5. PubMed ID: 21354707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
